Potential use of Immunodaat® (Botanical extract of Elderberry -Sambucus Nigra L.) in the management of Post Covid-19 symptoms- a comparative, multi-centric, randomized, clinical study

preprint OA: closed
📄 Open PDF View at publisher

Abstract

Background Immunodaat™, a proprietary botanical extract, contains standardized extract of Elderberry ( Sambucus Nigra L .). Elderberry is used as an immunity enhancer for prevention and management of various respiratory diseases and as an anti-oxidant. Objectives The present study evaluated the effect of Immunodaat™, in Post Covid-19 recovery. Methods An open labeled, comparative, randomized, multi-centric, prospective clinical study was conducted on 74 subjects who had post COVID-19 symptoms recovery from mild-moderate COVID-19 within the last 15 days. Subjects were divided equally, with 37 subjects in trial and control groups each, where subjects in trial group were given Immunodaat™ capsules in a dose of 250 mg Capsules twice daily along with the standard care for COVID-19 for consecutive 30 days while subjects in control group were given only the standard care for Post Covid. Subjects were evaluated for post clinical recovery signs and symptoms (like cough, fatigue, Myalgia, Joint pain, confusion, altered mood, anxiety, insomnia etc.) and lab parameters. Subjects were evaluated for quality of life using WHO QOL BREF. Results Continuous 30 days administration of Immunodaat™ showed a significant difference in reducing physical as well as mental symptoms when compared to the control group. Also, a significant improvement in quality of life was observed on WHO QOL BREF scale with the use of Immunodaat compared to the control group. Overall quality of life, energy levels and stamina levels improved with the use of Immunodaat™. Subjects showed excellent tolerability and did not have any adverse effect with the use of Immunodaat™. Conclusion The study concludes that use of Immunodaat™ over 30 days aided to normalize the physical and mental symptoms that occurred due to Post COVID and long COVID. Immunodaat™ can be considered as a safe and effective natural ingredient in the management of Post COVID-19 or long COVID condition.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00